IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 213 filers reported holding IMMUNOMEDICS INC in Q4 2018. The put-call ratio across all filers is 1.36 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $37,826,000 | +163.0% | 444,850 | +9.6% | 0.03% | +150.0% |
| Q2 2020 | $14,383,000 | +255.6% | 405,850 | +35.3% | 0.01% | +200.0% |
| Q1 2020 | $4,045,000 | -35.0% | 300,050 | +2.1% | 0.00% | -33.3% |
| Q4 2019 | $6,220,000 | +62.7% | 293,950 | +1.9% | 0.01% | +50.0% |
| Q3 2019 | $3,824,000 | -3.0% | 288,350 | +1.4% | 0.00% | 0.0% |
| Q2 2019 | $3,943,000 | -15.3% | 284,250 | +17.2% | 0.00% | -20.0% |
| Q1 2019 | $4,657,000 | +41.1% | 242,450 | +4.8% | 0.01% | +25.0% |
| Q4 2018 | $3,300,000 | -22.0% | 231,250 | +13.9% | 0.00% | -20.0% |
| Q3 2018 | $4,230,000 | -12.0% | 203,050 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $4,806,000 | +55.4% | 203,050 | -4.1% | 0.01% | +25.0% |
| Q1 2018 | $3,092,000 | +22.2% | 211,650 | +35.1% | 0.00% | +33.3% |
| Q4 2017 | $2,531,000 | +15.6% | 156,650 | 0.0% | 0.00% | +50.0% |
| Q3 2017 | $2,190,000 | +65.0% | 156,650 | +4.3% | 0.00% | 0.0% |
| Q2 2017 | $1,327,000 | +25.4% | 150,250 | -8.1% | 0.00% | +100.0% |
| Q1 2017 | $1,058,000 | +76.3% | 163,450 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $600,000 | +26.8% | 163,450 | +12.4% | 0.00% | 0.0% |
| Q3 2016 | $473,000 | +40.4% | 145,450 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $337,000 | -1.2% | 145,450 | +2.8% | 0.00% | 0.0% |
| Q1 2016 | $341,000 | -2.8% | 141,550 | +23.9% | 0.00% | 0.0% |
| Q4 2015 | $351,000 | +78.2% | 114,250 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $197,000 | -49.4% | 114,250 | +19.3% | 0.00% | 0.0% |
| Q2 2015 | $389,000 | +6.0% | 95,750 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $367,000 | -20.2% | 95,750 | 0.0% | 0.00% | -50.0% |
| Q4 2014 | $460,000 | +29.2% | 95,750 | 0.0% | 0.00% | +100.0% |
| Q3 2014 | $356,000 | +2.0% | 95,750 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $349,000 | -5.9% | 95,750 | +8.6% | 0.00% | 0.0% |
| Q1 2014 | $371,000 | +18.5% | 88,200 | +29.5% | 0.00% | 0.0% |
| Q4 2013 | $313,000 | -25.8% | 68,100 | 0.0% | 0.00% | -50.0% |
| Q3 2013 | $422,000 | +2.9% | 68,100 | -9.7% | 0.00% | 0.0% |
| Q2 2013 | $410,000 | – | 75,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 10,488,076 | $92,610,000 | 11.69% |
| First Light Asset Management, LLC | 2,048,643 | $18,090,000 | 6.07% |
| Foresite Capital Management III, LLC | 1,940,850 | $17,138,000 | 5.60% |
| DAFNA Capital Management LLC | 637,700 | $5,631,000 | 4.02% |
| ACUTA CAPITAL PARTNERS, LLC | 1,600,000 | $14,128,000 | 3.95% |
| Opaleye Management Inc. | 900,000 | $7,947,000 | 3.32% |
| Ghost Tree Capital, LLC | 1,200,000 | $10,596,000 | 2.20% |
| Iguana Healthcare Management, LLC | 325,000 | $2,870,000 | 1.62% |
| Healthcare Value Capital, LLC | 100,000 | $883,000 | 1.59% |
| Palo Alto Investors LP | 3,010,466 | $26,582,000 | 1.24% |